UBS AM’s QIAGEN NV QGENF Stock Holding History

UBS AM’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,892	Closed	-$821K	–	2861
2016 Q3	$821K	Buy	29,892 +9,100	+44%	+$250K	﹤0.01%	1765
2016 Q2	$453K	Hold	20,792	–	–	﹤0.01%	2003
2016 Q1	$464K	Sell	20,792 -9,990	-32%	-$223K	﹤0.01%	1969
2015 Q4	$851K	Buy	30,782 +5,164	+20%	+$143K	﹤0.01%	1807
2015 Q3	$661K	Hold	25,618	–	–	﹤0.01%	1876
2015 Q2	$635K	Hold	25,618	–	–	﹤0.01%	1927
2015 Q1	$646K	Sell	25,618 -8,448	-25%	-$213K	﹤0.01%	1832
2014 Q4	$799K	Hold	34,066	–	–	﹤0.01%	1694
2014 Q3	$776K	Hold	34,066	–	–	﹤0.01%	1652
2014 Q2	$833K	Hold	34,066	–	–	﹤0.01%	1644
2014 Q1	$718K	Buy	34,066 +16,100	+90%	+$339K	﹤0.01%	1686
2013 Q4	$428K	Hold	17,966	–	–	﹤0.01%	1896
2013 Q3	$384K	Hold	17,966	–	–	﹤0.01%	1923
2013 Q2	$358K	Buy	+17,966	New	+$358K	﹤0.01%	1878

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM's QGENF Position: Q4 2016 in Review

UBS AM sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 29,892 shares — an estimated $821K sold.

UBS AM first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $851K in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

UBS AM reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
UBS AM sold 29,892 QIAGEN NV shares in Q4 2016, an estimated $821K.
UBS AM first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
UBS AM's QIAGEN NV position peaked at $851K in Q4 2015.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on UBS AM's 13F filing for Q4 2016, filed 14 Feb 2017.